223 related articles for article (PubMed ID: 19075592)
1. Melatonin as a selective estrogen enzyme modulator.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Curr Cancer Drug Targets; 2008 Dec; 8(8):691-702. PubMed ID: 19075592
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
3. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
4. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
5. The selective estrogen enzyme modulator (SEEM) in breast cancer.
Chetrite GS; Pasqualini JR
J Steroid Biochem Mol Biol; 2001; 76(1-5):95-104. PubMed ID: 11384867
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.
González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Alvarez-García V; Sánchez-Barceló EJ; Cos S
Oncol Rep; 2010 Apr; 23(4):1173-8. PubMed ID: 20204307
[TBL] [Abstract][Full Text] [Related]
7. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
8. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer therapy based on melatonin.
Sanchez-Barcelo EJ; Mediavilla MD; Alonso-Gonzalez C; Rueda N
Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):108-16. PubMed ID: 22369716
[TBL] [Abstract][Full Text] [Related]
10. Melatonin-estrogen interactions in breast cancer.
Sánchez-Barceló EJ; Cos S; Mediavilla D; Martínez-Campa C; González A; Alonso-González C
J Pineal Res; 2005 May; 38(4):217-22. PubMed ID: 15813897
[TBL] [Abstract][Full Text] [Related]
11. Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis.
Alonso-González C; González A; Martínez-Campa C; Menéndez-Menéndez J; Gómez-Arozamena J; García-Vidal A; Cos S
Cancer Lett; 2016 Jan; 370(1):145-52. PubMed ID: 26497762
[TBL] [Abstract][Full Text] [Related]
12. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.
González A; Alvarez-García V; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
Curr Cancer Drug Targets; 2010 May; 10(3):279-86. PubMed ID: 20370689
[TBL] [Abstract][Full Text] [Related]
13. In situ production of estrogens in human breast carcinoma.
Suzuki T; Moriya T; Ishida T; Kimura M; Ohuchi N; Sasano H
Breast Cancer; 2002; 9(4):296-302. PubMed ID: 12459709
[TBL] [Abstract][Full Text] [Related]
14. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
15. Melatonin and mammary cancer: a short review.
Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD
Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777
[TBL] [Abstract][Full Text] [Related]
16. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
17. Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review).
Cos S; Alvarez-García V; González A; Alonso-González C; Martínez-Campa C
Oncol Lett; 2014 Aug; 8(2):487-492. PubMed ID: 25009641
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
19. Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.
González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Mateos S; Hill SM; Sánchez-Barceló EJ; Cos S
Oncol Rep; 2007 Apr; 17(4):947-53. PubMed ID: 17342341
[TBL] [Abstract][Full Text] [Related]
20. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.
Cos S; González A; Güezmes A; Mediavilla MD; Martínez-Campa C; Alonso-González C; Sánchez-Barceló EJ
Int J Cancer; 2006 Jan; 118(2):274-8. PubMed ID: 16080194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
